OvaReady: an automated device to prepare oocytes for IVF
Official title: OvaReady: An automated microfluidic oocyte retrieval and denudation device
Funded at Autoivf, INC. · NIH-11372993 · Data updated 2026-11-12
A new automated microfluidic device helps extract and prepare oocytes for IVF, aiming to make treatments faster, safer, and more accessible.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Autoivf, INC. NIH-funded |
| Lab location | 1 site (Natick, UNITED STATES) |
| Project start | September 21, 2021 |
| Project end | June 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $998,971 |
| NIH project number | 5R44HD105529-05 |
| Project ID | NIH-11372993 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals undergoing IVF who would benefit from automated oocyte retrieval and preparation, including those at satellite clinics seeking streamlined workflows.
✕Less likely to help
Patients not undergoing IVF or those whose treatment protocols do not involve oocyte preparation in this system would not benefit directly.
What this research studies
OvaReady is an automated microfluidic system designed to isolate and denude cumulus-oocyte-complexes from follicular fluid in a closed, single-touch process. It seeks to streamline oocyte preparation for either ICSI or cryopreservation, reducing manual steps and exposure to environmental variation. The project focuses on improving oocyte recovery, preserving quality, and enabling decentralized IVF services at satellite clinics. It aligns with goals to provide infertility diagnosis and treatment tools that work well in resource-limited settings. The effort includes refining the device for commercial use and regulatory approval, with emphasis on ease of use and scalable production.
Why it matters
Potential benefit: If successful, the device could make IVF more efficient, safer, and accessible to more patients, especially in settings with limited resources.
How similar studies have gone: Previous manual methods are standard; this device aims to outperform them with automation, showing promise in preliminary studies but needs full validation.
Where this research is happening
-
Autoivf, INC.
Natick, United States Active
Researchers
- Principal investigator: Ozkumur, Ismail Emre — Autoivf, INC.
- Study coordinator: Ozkumur, Ismail Emre
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.